Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency
利福昔明改变肠道菌群特征,但不影响全身炎症 - 常见变异性免疫缺陷症的随机对照试验
期刊:Scientific Reports
影响因子:3.8
doi:10.1038/s41598-018-35367-7
S F Jørgensen, M E Macpherson, T Bjørnetrø, K Holm, M Kummen, A Rashidi, A E Michelsen, T Lekva, B Halvorsen, M Trøseid, T E Mollnes, R K Berge, A Yndestad, T Ueland, T H Karlsen, P Aukrust, J R Hov, B Fevang
免疫
肠炎
Immunology/Inflammation
AROS